Sangamo Therapeutics Total Assets

Sangamo Therapeutics (SGMO) currently reports a total assets of $60M as of March 2026. That compares with $86M in the prior-year period — down 30.4% year over year. Use the charts on this page to explore Sangamo Therapeutics's total assets history and peer comparisons.

Sangamo Therapeutics's total assets decreased from $86M to $60M — a 30.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sangamo Therapeutics reported $60M in total assets as of March 2026. That compares with $86M in the prior-year period — down 30.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $60M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sangamo Therapeutics, and consider following SGMO for alerts when major investors trade the stock.

Sangamo Therapeutics is classified in the Healthcare sector. On total assets, it currently shows $60M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SGMO with unrelated industries.